Evaluation of Clinical Outcomes With the V-Go Wearable Insulin Delivery Device in Patients With Type 2 Diabetes | Zendy

Lisa T. Meade | Zendy; Dawn M. Battise | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Evaluation of Clinical Outcomes With the V-Go Wearable Insulin Delivery Device in Patients With Type 2 Diabetes

Author(s) -

Lisa T. Meade,

Dawn M. Battise

Publication year - 2021

Publication title -

clinical diabetes

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.931

H-Index - 37

eISSN - 1945-4953

pISSN - 0891-8929

DOI - 10.2337/cd20-0094

Subject(s) - medicine , insulin delivery , insulin , diabetes mellitus , medical prescription , type 2 diabetes , type 1 diabetes , wearable computer , intensive care medicine , endocrinology , pharmacology , computer science , embedded system

Uncontrolled type 2 diabetes can lead to a multitude of health complications. Insulin therapy is recommended when patients are unable to reach their A1C goal with oral or noninsulin injectable diabetes medications. This study evaluated the clinical benefits of switching from multiple daily insulin injections to a wearable insulin delivery device (V-Go). A retrospective chart review was conducted on 44 patients who received prescriptions for the V-Go at two family medicine offices. Investigators found a significant reduction in A1C and daily insulin requirements with no impact on weight or BMI.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research